Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
Da Costa
M
M
Department of Surgery, Addenbrooke's Hospital, Cambridge, UK.
Metcalfe
S
S
Calne
R Y
RY
D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051381:Rats; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous; D014230:Triazoles / Q000627:therapeutic use*
D001381:Azepines; D003524:Cyclosporins; D010972:Platelet Activating Factor; D014230:Triazoles; C063964:bepafant